Hemostasis Today

August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Zain Khalpey: Left Atrial Appendage Closure vs Oral Anticoagulation in Atrial Fibrillation
Aug 6, 2026, 15:46

Zain Khalpey: Left Atrial Appendage Closure vs Oral Anticoagulation in Atrial Fibrillation

Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared a post on LinkedIn about a recent article by Paschalis Karakasis, published in EP Europace, adding:

“Left Atrial Appendage Closure vs Oral Anticoagulation in Atrial Fibrillation.

A meta analysis of six randomized trials involving more than 7,000 patients compared left atrial appendage closure with oral anticoagulation for stroke prevention in atrial fibrillation.

LAAC was associated with fewer nonprocedural clinically relevant bleeding events, but a higher risk of ischemic stroke or systemic embolism.

There were no significant differences in overall stroke, major bleeding, hemorrhagic stroke, or mortality.

The findings suggest that LAAC should not be viewed as an equal replacement for anticoagulation in every patient.

Its role remains most relevant for carefully selected individuals who cannot tolerate long-term anticoagulation or have significant bleeding concerns.”

Title: Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials

Authors: Paschalis Karakasis, Stylianos Tzeis, Athanasios Samaras, Konstantinos Vlachos, Konstantinos Pamporis, Panagiotis Theofilis, Apostolos Tzikas, Antonios P Antoniadis, Pierre Jaïs, Nikolaos Fragakis

Zain Khalpey

Stay udpated on all scientific advances with Hemostasis Today.